CXCR6 and malaria: By validating new cell surface markers (CXCR6+ CD127−) using scRNAseq and functional experiments to identify high-confidence, bona-fide Tr1 cells, we were able to study the function and clinical relevance of Tr1 cells among children living in malaria-endemic Uganda.